A carregar...
5PSQ-009 Adequacy of use and effectiveness of glp-1 receptor agonists in real clinical practice
BACKGROUND: NICE guidelines recommend the use of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RA) for adults with type-2 diabetes who have a BMI of 35 kg/m(2) or higher, and continue therapy if a reduction of at least 1% in HbA1c and a weight loss of at least 3% in 6 months is achieved. PURPOSE:...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535169/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.363 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|